During the past decade, Teo Health SA - Saint Constantin Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Teo Health SA - Saint Constantin Hospital" are "Non-Small Cell Lung Cancer" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Teo Health SA - Saint Constantin Hospital" in a lesser frequency.

Most popular intervention types in "Teo Health SA - Saint Constantin Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Gemcitabine" (2 trials), "Atezolizumab" (1 trials) and "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Teo Health SA - Saint Constantin Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Teo Health SA - Saint Constantin Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Teo Health SA - Saint Constantin Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Teo Health SA - Saint Constantin Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".